Article
RT-PCR analysis may identify lymph node metastasis
Charlottesville, VA-Use of molecular analysis for the uroplakin II (UPII) gene may potentially be a more sensitive method than conventional histopathology for identifying lymph node metastasis in patients with urothelial bladder cancer, according to a joint University of Virginia/University of Western Ontario study appearing in Clinical Cancer Research (2001; 7:1516-22).
Related Videos
Study results affirm effectiveness of evolving prostate cancer therapies
Non–Muscle Invasive-Bladder Cancer Overview
Laura Davis, MD, on link between microplastics and bladder cancer
Roger Dmochowski, MD, on real-world persistence with vibegron for OAB
NMIBC Maintenance Therapy: Timing, Dosing, and Follow-Up
BRCA Mutations in mHSPC: Impact on Therapy Selection
Formulations, Food, and Frequency: Optimizing Absorption and Tolerability in Daily Practice
Defining and Managing BCG-Unresponsive NMIBC
Considerations for patient follow-up after onabotA administration
Mitchell Huang, MD, on the link between obesity and pain on transperineal biopsy
Related Content
